comparemela.com

Latest Breaking News On - Translational ocular - Page 1 : comparemela.com

OKYO Pharma LTD: OKYO Pharma Hosting Key Opinion Leader Event Introducing OK-101 as a Potential Treatment for Dry Eye Disease

Monday, November 14th @ 8 am ET, registration details below NEW YORK, Nov. 10, 2022 (GLOBE NEWSWIRE) OKYO Pharma Ltd (Nasdaq: OKYO; LSE: OKYO) ("OKYO" or the "Company"), an ophthalmology bio-pharmaceutical

Tufts-university
Massachusetts
United-states
Boston
Tufts-medical-center
Pedram-hamrah
Garys-jacob
Tufts-university-school-of-medicine
Pharma-ltd-nasdaq
Key-opinion-leader
Potential-treatment
Dry-eye

Investegate |OKYO Pharma LTD Announcements | OKYO Pharma LTD: OKYO Pharma Hosting Key Opinion Leader Event Introducing OK-101 as a Potential Treatment for Dry Eye Disease

Investegate announcements from OKYO Pharma LTD, OKYO Pharma Hosting Key Opinion Leader Event Introducing OK-101 as a Potential Treatment for Dry Eye Disease

Tufts-university
Massachusetts
United-states
Boston
United-kingdom
London
City-of
Tufts-medical-center
Pedram-hamrah
Garys-jacob
London-stock-exchange
Pharma-limited

OKYO Pharma Hosting Key Opinion Leader Event Introducing

Monday, November 14th @ 8 am ET, registration details below NEW YORK, Nov. 10, 2022 (GLOBE NEWSWIRE) OKYO Pharma Ltd (Nasdaq: OKYO; LSE: OKYO).

Tufts-university
Massachusetts
United-states
Boston
United-kingdom
London
City-of
Tufts-medical-center
Pedram-hamrah
Garys-jacob
London-stock-exchange
Pharma-limited

Form 424B4 OKYO Pharma Ltd

Form 424B4 OKYO Pharma Ltd
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Japan
Tufts-university
Massachusetts
United-states
United-kingdom
China
Guernsey
Australia
Ann-arbor
Michigan
District-of-columbia
State-of-new-york

vimarsana © 2020. All Rights Reserved.